QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
QQQ   299.94 (-2.83%)
AAPL   116.36 (-4.17%)
MSFT   227.39 (-1.82%)
FB   255.31 (-3.39%)
GOOGL   2,007.50 (-4.27%)
TSLA   563.00 (-5.84%)
AMZN   2,951.95 (-1.62%)
NVDA   463.73 (-6.97%)
BABA   226.69 (-3.08%)
CGC   30.86 (-0.99%)
GE   14.17 (+4.19%)
MU   85.05 (-4.36%)
NIO   35.21 (-7.61%)
AMD   73.96 (-5.81%)
T   29.99 (+1.25%)
F   12.65 (+3.10%)
ACB   9.61 (+0.10%)
DIS   201.91 (+6.27%)
BA   224.03 (+0.36%)
NFLX   493.33 (-4.47%)
PFE   34.35 (-0.12%)
Log in
NASDAQ:GBIO

Generation Bio Stock Forecast, Price & News

$32.03
-0.72 (-2.20 %)
(As of 03/8/2021 12:00 AM ET)
Add
Compare
Today's Range
$31.80
Now: $32.03
$35.50
50-Day Range
$26.00
MA: $32.71
$40.20
52-Week Range
$17.00
Now: $32.03
$55.72
Volume373,405 shs
Average Volume725,230 shs
Market Capitalization$1.78 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Generation Bio Co., a genetic medicines company, develops gene therapies for the treatment of rare and prevalent diseases. The company is developing a portfolio of programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was founded in 2016 and is headquartered in Cambridge, Massachusetts.
Generation Bio logo

Headlines

Generation Bio Appoints Ron Cooper to Its Board of Directors
February 18, 2021 |  finance.yahoo.com
Generation Bio Announces Closing of Public Offering
January 11, 2021 |  finance.yahoo.com
Generation Bio Announces Pricing of Public Offering
January 6, 2021 |  finance.yahoo.com
Generation Bio (GBIO) Catches Eye: Stock Jumps 6.1%
January 5, 2021 |  finance.yahoo.com
Is Generation Bio (GBIO) A Good Stock To Buy Now?
December 3, 2020 |  finance.yahoo.com
Generation Bio Inc.
August 19, 2020 |  marketwatch.com
Generation Bio EPS misses by $1.05
August 11, 2020 |  seekingalpha.com
Generation Bio names new finance chief
July 22, 2020 |  seekingalpha.com
See More Headlines

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:GBIO
CUSIPN/A
CIKN/A
Phone857-529-5908
Employees85
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$1.78 billion
Next Earnings Date3/9/2021 (Estimated)
OptionableNot Optionable

MarketRank

Overall MarketRank

1.55 out of 5 stars

Medical Sector

417th out of 1,971 stocks

Pharmaceutical Preparations Industry

205th out of 772 stocks

Analyst Opinion: 2.5Community Rank: 3.8Dividend Strength: 0.0Insider Behavior: 0.8Valuation: 0.6 5 -4 -3 -2 -1 -
$32.03
-0.72 (-2.20 %)
(As of 03/8/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive GBIO News and Ratings via Email

Sign-up to receive the latest news and ratings for GBIO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Generation Bio (NASDAQ:GBIO) Frequently Asked Questions

Is Generation Bio a buy right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Generation Bio in the last year. There are currently 6 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Generation Bio stock.
View analyst ratings for Generation Bio
or view top-rated stocks.

What stocks does MarketBeat like better than Generation Bio?

Wall Street analysts have given Generation Bio a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Generation Bio wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Generation Bio?

Generation Bio saw a decrease in short interest in January. As of January 29th, there was short interest totaling 1,630,000 shares, a decrease of 36.8% from the January 14th total of 2,580,000 shares. Based on an average daily trading volume, of 521,900 shares, the short-interest ratio is presently 3.1 days. Approximately 4.9% of the company's stock are short sold.
View Generation Bio's Short Interest
.

When is Generation Bio's next earnings date?

Generation Bio is scheduled to release its next quarterly earnings announcement on Tuesday, March 9th 2021.
View our earnings forecast for Generation Bio
.

How were Generation Bio's earnings last quarter?

Generation Bio Co. (NASDAQ:GBIO) posted its quarterly earnings results on Sunday, November, 15th. The company reported ($0.46) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.45) by $0.01.
View Generation Bio's earnings history
.

What price target have analysts set for GBIO?

6 brokerages have issued twelve-month price targets for Generation Bio's stock. Their forecasts range from $28.00 to $50.00. On average, they anticipate Generation Bio's stock price to reach $38.40 in the next twelve months. This suggests a possible upside of 19.9% from the stock's current price.
View analysts' price targets for Generation Bio
or view top-rated stocks among Wall Street analysts.

Who are Generation Bio's key executives?

Generation Bio's management team includes the following people:
  • Dr. Cameron Geoffrey McDonough, Pres, CEO, Sec. & Director (Age 51, Pay $515.83k)
  • Dr. Matthew Norkunas M.B.A., M.D., Chief Financial Officer (Age 43, Pay $264.36k)
  • Dr. Tracy Zimmermann Ph.D., Chief Devel. Officer (Age 51, Pay $342.96k)
  • Dr. Robert Kotin Ph.D., Co-Founder & Advisor (Age 65)
  • Dr. Matthew Stanton Ph.D., Chief Scientific Officer (Age 48)
  • Dr. Jennifer Elliott Esq., J.D., Ph.D., Chief Legal Officer
  • Ms. Sara Den Besten, Sr. VP of HR
  • Dr. Douglas Kerr M.B.A., M.D., Ph.D., Chief Medical Officer (Age 54)
  • Ms. Antoinette Paone M.B.A., M.S., Sr. VP & Head of Regulatory Affairs and Quality
  • Ms. Leslie Wolfe Ph.D., Sr. VP of Chemistry, Manufacturing & Control

Who are some of Generation Bio's key competitors?

What other stocks do shareholders of Generation Bio own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Generation Bio investors own include DocuSign (DOCU), NVIDIA (NVDA), Overstock.com (OSTK), The Boeing (BA), Pure Storage (PSTG), Mastercard (MA), QUALCOMM (QCOM), Riot Blockchain (RIOT), Twilio (TWLO) and Enphase Energy (ENPH).

When did Generation Bio IPO?

(GBIO) raised $126 million in an IPO on Friday, June 12th 2020. The company issued 7,400,000 shares at $16.00-$18.00 per share. J.P. Morgan, Jefferies and Cowen served as the underwriters for the IPO and Wedbush PacGrow was co-manager.

What is Generation Bio's stock symbol?

Generation Bio trades on the NASDAQ under the ticker symbol "GBIO."

Who are Generation Bio's major shareholders?

Generation Bio's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Price T Rowe Associates Inc. MD (7.89%), BlackRock Inc. (2.40%), JPMorgan Chase & Co. (1.40%), Victory Capital Management Inc. (1.29%), Harvard Management Co. Inc. (0.94%) and Bank of New York Mellon Corp (0.53%). Company insiders that own Generation Bio stock include Donald William Nicholson, Douglas Kerr, James E Flynn and Matthew Stanton.
View institutional ownership trends for Generation Bio
.

Which institutional investors are selling Generation Bio stock?

GBIO stock was sold by a variety of institutional investors in the last quarter, including Victory Capital Management Inc., and Wells Fargo & Company MN. Company insiders that have sold Generation Bio company stock in the last year include Douglas Kerr, and Matthew Stanton.
View insider buying and selling activity for Generation Bio
or view top insider-selling stocks.

Which institutional investors are buying Generation Bio stock?

GBIO stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., JPMorgan Chase & Co., Darwin Global Management Ltd., Price T Rowe Associates Inc. MD, Swiss National Bank, Credit Suisse AG, State of Wisconsin Investment Board, and Harvard Management Co. Inc.. Company insiders that have bought Generation Bio stock in the last two years include Donald William Nicholson, and James E Flynn.
View insider buying and selling activity for Generation Bio
or or view top insider-buying stocks.

How do I buy shares of Generation Bio?

Shares of GBIO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Generation Bio's stock price today?

One share of GBIO stock can currently be purchased for approximately $32.03.

How much money does Generation Bio make?

Generation Bio has a market capitalization of $1.78 billion.

How many employees does Generation Bio have?

Generation Bio employs 85 workers across the globe.

What is Generation Bio's official website?

The official website for Generation Bio is generationbio.com.

Where are Generation Bio's headquarters?

Generation Bio is headquartered at 301 BINNEY STREET, CAMBRIDGE MA, 02142.

How can I contact Generation Bio?

Generation Bio's mailing address is 301 BINNEY STREET, CAMBRIDGE MA, 02142. The company can be reached via phone at 857-529-5908 or via email at [email protected]


This page was last updated on 3/8/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.